Purchase Order 36C26326P0368
- Not listed
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and self-certified small disadvantaged business, received a $34,000 firm fixed-price purchase order from the Department of Veterans Affairs' Veterans Integrated Service Network 23 (Minneapolis, MN) for transcatheter aortic valve replacement (TAVR) systems. The award, issued on February 6, 2026, with a completion date of February 9, 2026, reflects no set-aside designation and represents a typical procurement structure...
- Edwards Lifesciences LLC, a leading cardiovascular medical device manufacturer and self-certified small disadvantaged business, has been awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network 23 (Minneapolis, Minnesota) for transcatheter aortic valve replacement (TAVR) systems and related cardiac technologies. The award, issued on March 27, 2026, with an ultimate completion date of April 26, 2026, represents a non-set-aside procurement reflecting Edwards...
- Edwards Lifesciences LLC received a $34,000 firm fixed-price purchase order from Veterans Integrated Service Network 23 (Minneapolis VA) for transcatheter aortic valve replacement (TAVR) systems, with an ultimate completion date of January 20, 2026. This contract, awarded on January 16, 2026, carries no set-aside designation and represents Edwards Lifesciences' specialized supply of advanced cardiovascular medical devices to the Department of Veterans Affairs. The award is structured as a...
- Edwards Lifesciences LLC was awarded a $34K firm fixed-price purchase order by Veterans Integrated Service Network 23 (Minneapolis, MN) for transcatheter aortic valve replacement (TAVR) systems, with an ultimate completion date of March 3, 2026. This award carries no set-aside designation and represents a direct procurement of specialized cardiovascular medical devices essential to the Department of Veterans Affairs' cardiac care mission. The contract reflects Edwards Lifesciences' established...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and self-certified small disadvantaged business, received a $34,000 firm fixed-price purchase order from Veterans Integrated Service Network 23 (Minneapolis, MN) for transcatheter aortic valve replacement (TAVR) systems. The award, issued on March 20, 2026, with an ultimate completion date of March 23, 2026, reflects the VA's critical need for specialized cardiovascular medical devices to support cardiac surgical programs...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation specializing in advanced cardiovascular medical devices, was awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network 23 (Minneapolis, MN) on March 13, 2026, with an ultimate completion date of March 16, 2026. The contract, which carries no set-aside designation, is for transcatheter aortic valve replacement (TAVR) systems and related cardiac technologies to support the Department of...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and recognized leader in cardiovascular medical devices, has been awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network 23 for TAVR (transcatheter aortic valve replacement) products. The contract, which was not set aside for any business category, is scheduled for completion by November 17, 2025, with performance occurring in Minneapolis, Minnesota. As the sole manufacturer of the...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a leader in cardiovascular medical devices, has been awarded a $34,000 firm fixed-price purchase order by the Department of Veterans Affairs' Veterans Integrated Service Network 23 (VISN 23). The contract, designated as a TAVR (transcatheter aortic valve replacement) award, does not utilize a set-aside designation and was awarded on July 23, 2025, with an ultimate completion date of the same day. The place of...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a self-certified small disadvantaged business, was awarded a firm fixed-price purchase order valued at $34,000 by the U.S. Department of Veterans Affairs through Veterans Integrated Service Network 23 on September 23, 2025. The contract, which is not set-aside designated, covers transcatheter aortic valve replacement (TAVR) medical devices and is scheduled for completion by September 24, 2025. The award supports the...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a self-certified small disadvantaged business, received a $34,000 firm fixed-price purchase order from Veterans Integrated Service Network 23 (Minneapolis) on January 30, 2026, for transcatheter aortic valve replacement (TAVR) systems. The contract, with an ultimate completion date of March 1, 2026, carries no set-aside designation and represents a sole-source procurement reflecting the contractor's exclusive...
Edwards Lifesciences LLC received a $34,000 firm fixed-price purchase order from Veterans Integrated Service Network 23 (Minneapolis, MN) for transcatheter aortic valve replacement (TAVR) systems, with an ultimate completion date of April 6, 2026. The contract was awarded without a set-aside designation on April 3, 2026. This purchase order falls within Edwards Lifesciences LLC's broader framework relationship with the Department of Veterans Affairs, where the company serves as a primary supplier of advanced cardiovascular devices including SAPIEN transcatheter heart valves and related cardiac implants to support the VA's specialized cardiac care mission for the veteran population. This award is supported by Edwards Lifesciences LLC's existing Indefinite Delivery Contract with VISN 23, part of the company's established contractual structure with the VA healthcare system. Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and self-certified small disadvantaged business, has received over 200 federal contract awards since 2025, consisting predominantly of firm fixed-price purchase orders from the Department of Veterans Affairs across multiple service networks. The company's exclusive manufacturing capability for specialized transcatheter heart valve technologies positions it as a sole-source supplier for these critical medical innovations essential to veteran patient outcomes.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
6515--PROS V23 618 UNU BILL & REPLACE 13255 TAVR (DOS: 04/02/2026) (VA-26-00059002) | 36C26326Q0529 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 | Award Notice 1/1 | 4/3/26, 2:42 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.0k | 4/2/26 |